市场调查报告书
商品编码
1439700
支架 - 全球市场回顾、竞争格局、市场预测(2030)Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2024-2030年预测期内,全球支架市场规模预计将以5.61%的复合年增长率成长。 由于慢性病盛行率增加、老年人口增加、对微创手术的需求增加以及不健康生活方式的增加等因素,预计该市场将在 2024 年至 2024 年期间出现增长。2030 年预测期内的支架市场。
支架市场动态
支架市场的主要驱动因素之一是慢性病盛行率的增加。 此外,慢性病盛行率的不断上升导致全球患者群体的死亡率上升。 例如,根据世界卫生组织(WHO)2022年发布的数据,全球每年有4,100万人(71%)因慢性病死亡。 此外,每年有1500万人死于30岁至69岁之间,每年有1790万人死于心血管疾病,其次是癌症(930万)、呼吸系统疾病(410万)和糖尿病(150万)。估计有10,000,000人)。 这四种疾病占慢性死亡的80%以上。 糖尿病患者更容易罹患冠状动脉疾病和心臟病等心血管疾病。 支架也可用于治疗胃癌和肺癌等癌症,以及呼吸系统和心血管疾病。 因此,这些慢性病的盛行率不断上升也导致了死亡率的大幅上升。 因此,提供支架治疗还可以最大限度地减少慢性病导致的死亡率上升,从而促进支架市场的需求和成长。
根据世界卫生组织 (WHO) 2022 年 10 月的数据,2015 年至 2050 年间,60 岁及以上人口将从 12% 至 22% 翻一番,到 2050 年达到 21 亿。事实确实如此。 此外,到2030年,世界上六分之一的人将超过60岁。 2020 年至 2050 年间,80 岁及以上的人口预计将增加两倍,达到 4.26 亿人。 因此,人口老化的增加将导致慢性病的增加。 人口老化更有可能患上冠状动脉疾病等疾病,需要植入支架作为治疗方案,这可能会增加需求并促进支架市场的成长。
然而,对支架的严格监管审批以及与支架置入相关的併发症可能会减缓支架市场的成长。
此外,持续的 COVID-19 大流行对支架市场产生了负面影响。 几乎所有国家都实施了全国封锁,限制了人员流动,中断了供应炼和物流,由于生产现场缺乏劳动力而降低了生产率,并减少了市场上产品的供应。由于短缺和优先治疗COVID-19 患者而被搁置。 例如,根据美国医院协会(2020)的数据,2020 年 3 月至 6 月期间,包括支架置入在内的 "选择性" 手术的减少估计给美国医院造成了 507 亿美元的损失。 据同一消息来源称,这些程序平均约占美国净收入的 31%。 然而,随着大规模疫苗接种和封锁规定的放鬆,供应链、物流和製造设备的恢復以及择期手术的增加,支架市场已恢復动力,预计在预测期内将进一步成长。
支架细分市场分析
就支架市场的产品类型细分而言,预计2022年冠状动脉支架将占最高占有率。 为了避免冠状动脉阻塞引起的心臟疾病,引入支架来治疗动脉阻塞。 根据世界卫生组织2022年数据,2019年全球约有1,790万人因心血管疾病死亡。 在 1700 万人过早死亡(70 岁以下)中,38% 是由于心血管疾病。 因此,由于心血管疾病的盛行率不断增加,死亡率也不断上升。 因此,透过提供冠状动脉支架治疗,可以抑制这些心血管疾病导致的死亡率,这将引起冠状动脉支架市场的成长,并带动2024年至2030年整体支架市场的成长。
本报告提供了全球支架市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Stents Market By Product Type (Coronary, Venous, Biliary, Peripheral And Others), By Material Type (Polymer, Alloy And Metal), By Type (Self-Expanding And Balloon-Expandable Stents), By End-User Type (Hospitals And Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of chronic diseases and rise in geriatric population.
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2024 to 2030. The stents market is witnessing a positive growth owing to the factors such as increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, thereby all factors contributing to the growth of stents market during the forecast period from 2024-2030.
Stents Market Dynamics:
One of the main drivers of the stents market is the increasing prevalence of chronic diseases. Furthermore, the rise in the prevalence of chronic diseases will lead to an increase in the mortality rate among the patient population globally. For instance, according to the dada published by World Health Organization (WHO) in 2022, each year 41 million or 71% deaths globally takes place due to chronic diseases. Further, it is estimated that 15 million people aged 30-69 years die each year, 17.9 million die due to cardiovascular diseases annually, followed by cancer (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). All these four diseases account for over 80% of all chronic deaths. People living with diabetes are more prone to cardiovascular diseases such as coronary artery disease, heart attack, and others. Moreover, stents can be used to treat cancers such as stomach, lung and others as well as respiratory and cardiovascular diseases. Therefore, owing to a rise in the prevalence of these chronic diseases, the death rate is also increasing significantly. Thus, by providing the treatment with the help of stents, the mortality rate that is increasing as a result of chronic diseases can also be minimized, thereby driving the demand and growth of stents market.
Moreover, another key factor which is responsible for the growth of stents market is rise in geriatric population, according to World Health Organization (WHO) October 2022 data, it was estimated that between year 2015-2050 people of age 60 and above will be doubled from 12-22% and will reach 2.1 billion by 2050. Further, by 2030, 1 in 6 people in the world will age 60 years or above. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, rise in geriatric population will lead to rise in chronic diseases as this population have more chances of getting diseases such as coronary artery diseases and others which require implantation of stents as their treatment solution, which can enhance the growth of stents market as the demand will rise.
However, stringent regulatory approvals for stents and complications associated with implantation of stents can slow down the stents market growth.
Additionally, the ongoing COVID-19 pandemic has negatively impacted the stents market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing rate due to which there was product shortage in the market, elective surgeries were not given priority as COVID-19 patients were given more preference in terms of treatment. For instance, as per the American Hospital Association 2020, in between March and June 2020, there had been an estimated loss of USD 50.7 billion to the United States hospitals as a result of the reduction observed in "elective" procedures including stents implantation. As per the same source, on an average these procedures had accounted to about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, and manufacturing units, increase in the elective surgeries, the stents market has picked momentum and is expected to further grow during the forecast period.
Stents Market Segment Analysis:
Stents market by Product Type (Coronary, Venous, Biliary and Peripheral, Others), by Material Type (Polymer, Alloy and Metal ), by Type (Self-Expanding and Balloon-Expandable Stents), by End-User Type (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In by product type segment of stents market, coronary stents are estimated to hold highest share in year 2022, to avoid the heart attack which is caused due to blockage of coronary arteries, stents can be introduced to treat blocked arteries. According to WHO 2022 data, in 2019 approximately 17.9 million people died due to cardiovascular diseases globally. Out of 17 million premature death (people of age under 70), 38% deaths were caused due to cardiovascular diseases. Therefore, due to increasing prevalence of cardiovascular diseases, death rate is also increasing. Thus, providing treatment with the help of coronary stents, mortality rate due to these cardiovascular diseases can be limited, this induces the growth of coronary stents market leading to the growth of overall stents market forcast during (2024-2030).
The rising approval and launch of coronary stent will alos promote the demand of stents, leading to an overall growth of the stents market, for instance, in September 2022, BIOTRONIK, a leading medical device company, announced U.S. Food and Drug Administration (FDA) approval of its Orsiro® mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES) in the US.
Therefore, increasing prevalence of cardiovascular diseases and approval & launch of coronary stents, increases the stents demand thereby, driving the growth of the overall stents market during the forecast period from 2024-2030.
North America is expected to dominate the overall Stents Market:
Among all the regions, North America is estimated to dominate the global stents market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as rising prevalence of sedentary lifestyle and rising technological advancements associated with the stents increases the stents market in North America.
According to Centers For Disease Control and Prevention (CDC) January 2022 data, in 2022, 25% of the US adults population were found to be physically inactive. In 2020, more then 15% adults were physically inactive. Therefore, rising prevalence of sedentary lifestyle enhance the risk of developing diseases such as diabetes, cancer and others among the US population which require stents as a treatment solution ultimately increase the demand of stents thereby, propelling the growth of stents market in North America.
Furthermore, technological advancements also driving the growth of stents market. For instance, in August 2019, FDA approved treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents are approved to treat obstructed lesions in arteries of the legs.
Further, in January 2020, FDA Approved 3D-printed airway stents developed by Cleveland Clinic doctor, these stents are used to keep the airways open of patients having serious disorders, such as tumors, inflammation, trauma or other masses.
Thus, all above mentioned factors wil surge the demand of stents thereby, driving the growth of the overall stents market during the forecast period from 2024-2030.
Stents Market Key Players:
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
Recent Developmental Activities in the Stents Market:
In June 2022, Abbott, a global healthcare leader announced its XIENCE family of stents has received FDA approval for one-month DAPT labeling for high bleeding risk (HBR) patients in the U.S
In October 2020, Medtronic plc, a global leader in medical technology, announced that it has received FDA approval for the Abre(TM) venous self-expanding stent system in U.S for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction
In March 2019, BD, a leading global medical technology company, received U.S. FDA premarket approval for first venous stent to treat iliofemoral venous occlusive disease
Key Takeaways from the Stents Market Report Study:
Target Audience who can be benefited from this Stents Market Report Study
Frequently Asked Questions for Stents Market:
Stents are tiny metal or plastic tubes which are inserted in a blocked passageway to keep it open. Depending on where it is placed stent restores the flow of blood or other fluids.
Global stents market is estimated to grow at a CAGR of 5.61% during the forecast period from 2024 to 2030.
The stents market is witnessing a positive market growth owing to the factors such as, increasing prevalence of chronic diseases, rise in geriatric population, increasing demand of minimally invasive procedures, increase in unhealthy lifestyle, surge in sedentary lifestyle, technological advancements in product offerings.
Some of the key market players operating in the stents market include Boston Scientific Corporation, BD, Medtronic, Abbott, Cook, Merit Medical Systems, Novatech SA, Terumo Europe NV, MicroPort Scientific Corporation, Fuji Systems Corp, MICRO-TECH EUROPE, Vascular Concepts, Olympus America, W. L. Gore & Associates, Inc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Teleflex Incorporated, Elixir Medical Corporation, REVA Medical, LLC, among others.
North America is estimated to dominate the global stents market. Factors contributing to the growth of stents market includes rising prevalence of sedentary lifestyle, increasing product approval in the region, and rising technological advancements associated with the stents are drivgn the North America stents market.